๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
Verrica Pharmaceuticals Inc. (VRCA)
NASDAQ: VRCA ยท Real-Time Price ยท USD
2.740
-0.145 (-5.03%)
At close: Nov 20, 2026, 4:00 PM EST
2.730
-0.010 (-0.36%)
After-hours: Nov 20, 2026, 7:30 PM EST

Verrica Pharmaceuticals Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
22.8935.587.575.129.0312
Revenue Growth
-25.75%370.22%47.66%-43.27%-24.73%-
Gross Profit
9.7223.28-7.01-15.92-3.89-3.93
Operating Income
-40.23-11.94-65.84-63.22-21.3-30.91
Net Income
-43.32-17.89-76.58-67-24.49-35.08
Earnings Per Share
-2.22-1.68-14.78-14.78-7.17-13.00
EPS Growth
------

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
14.3930.1546.3369.5534.2770.35
Total Debt
11.641.6345.9445.511.5343.41
Net Cash (Debt)
2.7628.520.3924.0432.7526.95
Net Cash Growth
-7211.79%-98.38%-26.60%21.53%-4.67%
Net Cash Per Share
0.142.680.085.309.599.96

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
--17.63-60.93-38.58-18.65-27.58
Capital Expenditures
---0.03-0.36-0.3-0.88
Free Cash Flow
--17.63-60.95-38.94-18.95-28.47
Free Cash Flow Growth
------

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
42.46%65.44%-92.70%--43.08%-32.74%
Operating Margin
-175.73%-33.56%-870.16%-1233.84%-235.78%-257.57%
Pretax Margin
-189.23%-50.27%-1012.15%-1307.47%-271.11%-292.33%
Profit Margin
-189.23%-50.27%-1012.15%-1307.47%-271.11%-292.33%
FCF Margin
--49.55%-805.63%-759.93%-209.83%-237.21%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
2.063.748.3860.0912.5121.01